Results 111 to 120 of about 219,523 (189)

Longer Sleep Duration Predicts Progression to Bipolar or Psychotic Disorders in Youth Accessing Early Intervention Mental Health Services

open access: yesBipolar Disorders, Volume 28, Issue 7, November 2026.
ABSTRACT Background While growing evidence implicates sleep‐wake and circadian rhythm disturbances (SCRDs) in the onset and course of mood and psychotic disorders, longitudinal studies using objective measures are limited. This clinical cohort study examined whether actigraphy‐derived SCRDs (sleep duration, timing, and efficiency) predicted transition ...
Joanne S. Carpenter   +11 more
wiley   +1 more source

Evaluating Whole Fruit Feijoa Powder for Type 2 Diabetes Risk Prevention: A Randomised Controlled Trial

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 10709-10724, November 2026.
ABSTRACT Background Low energy diets (LEDs) are effective for body weight (BW) loss and improvement of type 2 diabetes (T2D) risk biomarkers. Emerging evidence suggests that whole fruit feijoa powder, rich in polyphenols and abscisic acid, may further support T2D prevention.
I. A. Mohamed   +6 more
wiley   +1 more source

Atypical antipsychotics for bipolar disorder: Overblown or blown over?

open access: yes, 2007
Atypical antipsychotics for bipolar disorder: Overblown or blown ...
Seetal Dodd (13093767)   +2 more
core  

Typical and Atypical Antipsychotics in Acute Mania: Comparison of Effectiveness

open access: yes, 2017
IntroductionMania is challenging to treat. Typical antipsychotics may be more efficient compared with atypical antipsychotics, however, with unfavourable side effects.ObjectivesTo help the clinician choose between typical and atypical antipsychotics ...
L.M. Kai   +4 more
core   +1 more source

Understanding Risks in the Care of People With Dementia in Acute Hospital Settings: Definitions, Types and Management Strategies—A Scoping Review

open access: yesJournal of Clinical Nursing, Volume 35, Issue 11, Page 4708-4724, November 2026.
ABSTRACT Aims This scoping review explores how risk is defined, managed and mitigated in the care of people with dementia in acute hospital settings. Methods This scoping review followed Arksesy and O'Malley's five‐stage framework (2005) and was guided by the Joanna Briggs Institute methodology.
Ashitha Bhaskaran   +4 more
wiley   +1 more source

Dedicated follower[s] of fashion [Replies to The rise and fall of the atypical antipsychotics]

open access: yes, 2011
https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/rise-and-fall-of-the-atypical-antipsychotics ...
Adams, Clive E.
core   +1 more source

Synthesis of Nitrogen‐Containing Heterocyclic Scaffolds and Applications in Scaffold Hopping: Development of an Aripiprazole Analog

open access: yesChemMedChem, Volume 21, Issue 20, 28 October 2026.
A series of 12 novel fused [6,6] saturated and unsaturated nitrogen bicycles is synthesized in three to five steps and expands the CRAFT library's fragment space. A 2,6‐naphthyridin‐3‐ol core replaces the dihydroquinolinone scaffold of aripiprazole, a scaffold‐hopping strategy.
Temitayo Omowumi Alegbejo Price   +12 more
wiley   +1 more source

Treatment of bipolar mania with atypical antipsychotics.

open access: yes, 2004
Acute manic episodes in bipolar disorder require rapid and effective relief. Pharmacotherapy has traditionally involved mood stabilizers such as lithium or divalproex. Evidence for the efficacy of atypical antipsychotics to treat bipolar mania, either as
KNR Chengappa (14528615)   +2 more
core  

[Diabetes and second-generation (atypical) antipsychotics]

open access: yes, 2009
International audienceSchizophrenia is a common psychiatric illness (1% of the general population), characterized by the association of positive and negative symptoms and cognitive disorders.
S. Chabroux   +5 more
core   +1 more source

Antipsychotic medication for people with first episode schizophrenia: an exploratory economic analysis of alternative treatment algorithms [PDF]

open access: yes
Available clinical evidence suggests that the newer antipsychotics are similar to conventional antipsychotics for positive symptom control. It has been suggested that they may also be superior for negative symptoms and side effects, but the evidence for ...
Linda Davies, Shon Lewis
core  

Home - About - Disclaimer - Privacy